The Industry's Favourite ADC Event Returns | Greater Insights. Stronger Connections.
The Annual Orientation Point, Community Anchor Event & Largest Gathering for the European ADC Field
Solidifying ADCs as Standard of Care Therapies by Overcoming Resistance, Improving Response Rates & Expanding into Subpopulations Through Differentiated Design, Clinical & Manufacturing Strategies
Facilitating Groundbreaking ADC Insights & Connections
As ADCs continue to redefine the standard of care in oncology, breakthrough clinical readouts, expanding approvals in earlier treatment settings, and a wave of landmark dealmaking have cemented ADCs as one of biopharma's most sought-after areas of investment. From Novartis' billion-dollar technology partnership with Myricx Bio to Gilead's acquisition of Tubulis, the industry's leading players are racing to secure differentiated linker-payload technologies, unlock novel targets, and develop the next generation of transformative ADC therapies for patients with hard-to-treat cancers.
Returning as Europe's largest and longest-standing annual meeting for the ADC community, the 17th World ADC London returns in March as the definitive week to benchmark against industry leaders, validate internal strategies, forge strategic partnerships, and shape the future of ADC development. Bringing together 700+ senior leaders from biopharma, biotech, academia, clinical research, investment, and solution providers, this is where the brightest minds and most innovative companies converge to accelerate progress across the field.
Featuring five streams of end-to-end content spanning discovery, preclinical and translational development, clinical lessons, process and analytical development, and manufacturing and supply chain, the 2027 agenda is curated to spotlight next-generation conjugate design, strategies to overcome resistance mechanisms, and the latest innovations accelerating ADCs towards clinical validation and earlier lines of treatment.
As investment accelerates and competition for differentiated ADC technologies intensifies, this is the must-attend forum for the European and global ADC community to uncover breakthrough insights, benchmark against industry leaders, validate internal strategies, forge strategic partnerships, and gain the market intelligence needed to shape the next wave of ADC innovation.
Whether you're racing to develop the next blockbuster beyond Enhertu, overcome resistance mechanisms, unlock novel targets, or bring differentiated ADCs to patients faster, World ADC London is your annual opportunity to stay ahead of the trends, technologies, and partnerships defining the future of the field.
This is the most comprehensive meeting on the ADC modality and the best place to meet innovators in the field.
This meeting offers a valuable exchange with experts across different fields, with the investor perspective standing out as particularly enlightening. It is a strong opportunity to build a more rounded understanding of ADCs - appreciating not only the scientific and clinical dimensions, but also how the field is viewed by investors and other key stakeholders.
I have been attending World ADC for many years, but every year, I learn something new that changes how we approach our work. Whether it's a key piece of data from a presentation or an insightful comment by a colleague, it's always worth the trip.
This is the most important conference for networking in the ADC field, connecting with long-established scientists as well as making new connections with newcomers who bring new ideas for improving the therapeutic index of ADCs.
World ADC London brings together the leaders and innovators shaping the future of ADCs. For me, the value lies in the quality of the dialogue, exchanging perspectives on where the field is heading, identifying opportunities for collaboration and ensuring that innovation continues to translate into meaningful outcomes for patients.
Explore the Preliminary Agenda
- 700+ ADC Industry Leaders Across Biopharma, Academia & Solution Providers
- 90+ Global ADC Experts & Industry Visionaries
- 5 Tracks of End-to-End ADC Innovation
- Brand-New Partnering Platform & Enhanced Networking Experiences
- Europe's Largest Gathering of the ADC Community
A Snapshot of Your World-Class Speaker Faculty
Cutting-Edge, End-to-End Scientific Content for All Stages of ADC Development
From new entrants to long-standing experts in the ADC field, the 2027 programme will delve into:
Why World ADC London Remains the Industry's Annual Meeting Point
For 17 years, World ADC London has been the forum where new ideas are challenged, partnerships are formed, and the industry's biggest opportunities are debated. As competition intensifies and innovation accelerates, it remains the place to understand where the field is heading next.
700+
ADC Industry Leaders Under One Roof
90+
Global Speaker Faculty
14+
Hours of Dedicated Networking & Partnering
5
Dedicated Tracks of Content
1
Unmissable Event
Official Partners
Lead Partner
Senior Partners
Attending Companies Include
Explore the Preliminary Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.